Your browser doesn't support javascript.
loading
Ventilatory capacity in CLAD is driven by dysfunctional airway structure.
Kerckhof, Pieterjan; Ambrocio, Gene P L; Beeckmans, Hanne; Kaes, Janne; Geudens, Vincent; Bos, Saskia; Willems, Lynn; Vermaut, Astrid; Vermant, Marie; Goos, Tinne; De Fays, Charlotte; Aversa, Lucia; Mohamady, Yousry; Vanstapel, Arno; Orlitová, Michaela; Van Slambrouck, Jan; Jin, Xin; Varghese, Vimi; Josipovic, Iván; Boone, Matthieu N; Dupont, Lieven J; Weynand, Birgit; Dubbeldam, Adriana; Van Raemdonck, Dirk E; Ceulemans, Laurens J; Gayan-Ramirez, Ghislaine; De Sadeleer, Laurens J; McDonough, John E; Vanaudenaerde, Bart M; Vos, Robin.
Afiliación
  • Kerckhof P; Laboratory of Respiratory Diseases and Thoracic Surgery (BREATHE), Department of CHROMETA, KU Leuven, Leuven, Belgium.
  • Ambrocio GPL; Laboratory of Respiratory Diseases and Thoracic Surgery (BREATHE), Department of CHROMETA, KU Leuven, Leuven, Belgium; Division of Pulmonary Medicine, Department of Internal Medicine, University of the Philippines - Philippine General Hospital, Manilla, The Philippines.
  • Beeckmans H; Laboratory of Respiratory Diseases and Thoracic Surgery (BREATHE), Department of CHROMETA, KU Leuven, Leuven, Belgium.
  • Kaes J; Laboratory of Respiratory Diseases and Thoracic Surgery (BREATHE), Department of CHROMETA, KU Leuven, Leuven, Belgium.
  • Geudens V; Laboratory of Respiratory Diseases and Thoracic Surgery (BREATHE), Department of CHROMETA, KU Leuven, Leuven, Belgium.
  • Bos S; Newcastle University, Translational and Clinical Research Institute, Newcastle upon Tyne, United Kingdom.
  • Willems L; Laboratory of Respiratory Diseases and Thoracic Surgery (BREATHE), Department of CHROMETA, KU Leuven, Leuven, Belgium.
  • Vermaut A; Laboratory of Respiratory Diseases and Thoracic Surgery (BREATHE), Department of CHROMETA, KU Leuven, Leuven, Belgium.
  • Vermant M; Laboratory of Respiratory Diseases and Thoracic Surgery (BREATHE), Department of CHROMETA, KU Leuven, Leuven, Belgium.
  • Goos T; Laboratory of Respiratory Diseases and Thoracic Surgery (BREATHE), Department of CHROMETA, KU Leuven, Leuven, Belgium.
  • De Fays C; Laboratory of Respiratory Diseases and Thoracic Surgery (BREATHE), Department of CHROMETA, KU Leuven, Leuven, Belgium; Pole of Pneumology, ENT, and Dermatology, Institute of Experimental and Clinical Research, Université Catholique de Louvain, Brussels, Belgium.
  • Aversa L; Laboratory of Respiratory Diseases and Thoracic Surgery (BREATHE), Department of CHROMETA, KU Leuven, Leuven, Belgium.
  • Mohamady Y; Laboratory of Respiratory Diseases and Thoracic Surgery (BREATHE), Department of CHROMETA, KU Leuven, Leuven, Belgium.
  • Vanstapel A; Laboratory of Respiratory Diseases and Thoracic Surgery (BREATHE), Department of CHROMETA, KU Leuven, Leuven, Belgium; Department of Pathology, University Hospitals Leuven, Leuven, Belgium.
  • Orlitová M; Department of Cardiovascular Sciences, KU Leuven, Leuven, Belgium.
  • Van Slambrouck J; Laboratory of Respiratory Diseases and Thoracic Surgery (BREATHE), Department of CHROMETA, KU Leuven, Leuven, Belgium.
  • Jin X; Laboratory of Respiratory Diseases and Thoracic Surgery (BREATHE), Department of CHROMETA, KU Leuven, Leuven, Belgium.
  • Varghese V; Laboratory of Respiratory Diseases and Thoracic Surgery (BREATHE), Department of CHROMETA, KU Leuven, Leuven, Belgium; Department of Heart and Lung Transplant, Yashoda Hospitals, Hyderabad, India.
  • Josipovic I; Department of Physics and Astronomy, UGCT, Radiation Physics, Ghent University, Gent, Belgium.
  • Boone MN; Department of Physics and Astronomy, UGCT, Radiation Physics, Ghent University, Gent, Belgium.
  • Dupont LJ; Department of Respiratory Diseases, University Hospitals Leuven, Leuven, Belgium.
  • Weynand B; Department of Pathology, University Hospitals Leuven, Leuven, Belgium.
  • Dubbeldam A; Department of Radiology, University Hospitals Leuven, Leuven, Belgium.
  • Van Raemdonck DE; Department of Thoracic Surgery, University Hospitals Leuven, Leuven, Belgium.
  • Ceulemans LJ; Department of Thoracic Surgery, University Hospitals Leuven, Leuven, Belgium.
  • Gayan-Ramirez G; Laboratory of Respiratory Diseases and Thoracic Surgery (BREATHE), Department of CHROMETA, KU Leuven, Leuven, Belgium.
  • De Sadeleer LJ; Laboratory of Respiratory Diseases and Thoracic Surgery (BREATHE), Department of CHROMETA, KU Leuven, Leuven, Belgium; Cell Circuits in Systems Medicine of Lung Disease (Schiller Lab), Institute of Lung Health and Immunity (LHI) / Comprehensive Pneumology Centre (CPC), German Centre for Lung Researc
  • McDonough JE; Department of Medicine, McMaster University, Firestone Institute of Respiratory Health, Hamilton, Canada.
  • Vanaudenaerde BM; Laboratory of Respiratory Diseases and Thoracic Surgery (BREATHE), Department of CHROMETA, KU Leuven, Leuven, Belgium.
  • Vos R; Department of Respiratory Diseases, University Hospitals Leuven, Leuven, Belgium. Electronic address: robin.vos@uzleuven.be.
EBioMedicine ; 101: 105030, 2024 Mar.
Article en En | MEDLINE | ID: mdl-38394744
ABSTRACT

BACKGROUND:

Chronic lung allograft dysfunction (CLAD) encompasses three main phenotypes bronchiolitis obliterans syndrome (BOS), restrictive allograft syndrome (RAS) and a Mixed phenotype combining both pathologies. How the airway structure in its entirety is affected in these phenotypes is still poorly understood.

METHODS:

A detailed analysis of airway morphometry was applied to gain insights on the effects of airway remodelling on the distribution of alveolar ventilation in end-stage CLAD. Ex vivo whole lung µCT and tissue-core µCT scanning of six control, six BOS, three RAS and three Mixed explant lung grafts (9 male, 9 female, 2014-2021, Leuven, Belgium) were used for digital airway reconstruction and calculation of airway dimensions in relation to luminal obstructions.

FINDINGS:

BOS and Mixed explants demonstrated airway obstructions of proximal bronchioles (starting at generation five), while RAS explants particularly had airway obstructions in the most distal bronchioles (generation >12). In BOS and Mixed explants 76% and 84% of bronchioles were obstructed, respectively, while this was 22% in RAS. Bronchiolar obstructions were mainly caused by lymphocytic inflammation of the airway wall or fibrotic remodelling, i.e. constrictive bronchiolitis. Proximal bronchiolectasis and imbalance in distal lung ventilation were present in all CLAD phenotypes and explain poor lung function and deterioration of specific lung function parameters.

INTERPRETATION:

Alterations in the structure of conducting bronchioles revealed CLAD to affect alveolar ventilatory distribution in a regional fashion. The significance of various obstructions, particularly those associated with mucus, is highlighted.

FUNDING:

This research was funded with the National research fund Flanders (G060322N), received by R.V.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Bronquiolitis Obliterante / Trasplante de Pulmón / Obstrucción de las Vías Aéreas Límite: Female / Humans / Male Idioma: En Revista: EBioMedicine Año: 2024 Tipo del documento: Article País de afiliación: Bélgica

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Bronquiolitis Obliterante / Trasplante de Pulmón / Obstrucción de las Vías Aéreas Límite: Female / Humans / Male Idioma: En Revista: EBioMedicine Año: 2024 Tipo del documento: Article País de afiliación: Bélgica